Alexander Pearson to Drug Administration Schedule
This is a "connection" page, showing publications Alexander Pearson has written about Drug Administration Schedule.
Connection Strength
0.071
-
In Silico Models Accurately Predict In Vivo Response for IL6 Blockade in Head and Neck Cancer. Cancer Res. 2020 04 01; 80(7):1451-1460.
Score: 0.040
-
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer. Invest New Drugs. 2016 08; 34(4):481-9.
Score: 0.031